SCHEMBL3973408

SCHEMBL3973408

CC1(C(F)(F)F)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6119389 1.00 — —
SCHEMBL25738156 0.81 CHRM2 (0.31) —
SCHEMBL27225779 0.78 — —
SCHEMBL10820230 0.75 — —
SCHEMBL24653609 0.75 — —
SCHEMBL13856024 0.75 — —
SCHEMBL11109279 0.73 — —
SCHEMBL20869656 0.69 — —
SCHEMBL14224329 0.69 — —
SCHEMBL2114500 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575785-B1 3,4-dimethyl-2,5,6-tris/p-sulfonatophenyl)-1-phosphanorbornadiene, process for its preparation and process for hydroformulation of olefinic unsaturated compounds HOECHST AG (DE) 1997-01-08 — — EP claimed
US-20240158392-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES JANSSEN RESEARCH & DEVELOPMENT, LLC 2024-05-16 — — US disclosed
US-11845752-B2 Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B ALIGOS THERAPEUTICS, INC. (US) 2023-12-19 — — US disclosed
EP-4284801-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES Janssen Biotech, Inc. (US) 2023-12-06 — — EP disclosed
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 — — US disclosed
EP-4229062-A1 BICYCLIC COMPOUNDS Aligos Therapeutics, Inc. (US) 2023-08-23 — — EP disclosed
EP-4214214-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 — — EP disclosed
US-11710854-B2 Functional epoxides in catalyst-based electrolyte compositions for Li-ion batteries ENEVATE CORPORATION (US) 2023-07-25 — — US disclosed
US-11710854-B2 Functional epoxides in catalyst-based electrolyte compositions for Li-ion batteries ENEVATE CORPORATION (US) 2023-07-25 — — US disclosed
US-11472791-B2 Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors INCYTE CORPORATION (US) 2022-10-18 — — US disclosed
US-6020451-A Compositions of polytetramethylene ether glycols and polyoxy alkylene polyether polyols having a low degree of unsaturation BASF CORPORATION (US) 2000-02-01 — — US disclosed
US-5998574-A BLENDS BASF CORPORATION (US) 1999-12-07 — — US disclosed
EP-0850258-A1 COMPOSITIONS OF POLYTETRAMETHYLENE ETHER GLYCOLS AND POLYOXY ALKYLENE POLYETHER POLYOLS HAVING A LOW DEGREE OF UNSATURATION BASF CORPORATION (US) 1998-07-01 — — EP disclosed
WO-1998001492-A1 COMPOSITIONS OF POLYTETRAMETHYLENE ETHER GLYCOLS AND POLYOXY ALKYLENE POLYETHER POLYOLS HAVING A LOW DEGREE OF UNSATURATION BASF CORPORATION (DE) 1998-01-15 — — WO disclosed
US-5690909-A USEFUL AS NMR AND X-RAY DIAGNOSTIC AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 1997-11-25 — — US disclosed
EP-0700393-B1 MACROCYCLIC METAL COMPLEXES CONTAINING FLUORINE SCHERING AG (DE) 1997-10-22 — — EP disclosed
EP-0700393-A1 MACROCYCLIC METAL COMPLEXES CONTAINING FLUORINE SCHERING AG (DE) 1996-03-13 — — EP disclosed
WO-1994027978-A1 MACROCYCLIC METAL COMPLEXES CONTAINING FLUORINE SCHERING AKTIENGESELLSCHAFT (DE) 1994-12-08 — — WO disclosed
US-4568775-A FROM TETRAHYDROFURAN IN PRESENCE OF HETEROPOLY-ACID CATALYST ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1986-02-04 — — US disclosed
EP-0126471-A2 Process for producing polyetherglycol Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-11-28 — — EP disclosed
Send feedback